A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome
- PMID: 29054530
- PMCID: PMC5794609
- DOI: 10.1016/j.kint.2017.08.013
A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome
Abstract
Diabetic kidney disease is the leading cause of kidney failure. However, studies of molecular mechanisms of early kidney damage are lacking. Here we examined for possible linkage between transcriptional regulation and quantitative structural damage in early diabetic kidney disease in Pima Indians with type 2 diabetes. Tissue obtained from protocol kidney biopsies underwent genome-wide compartment-specific gene expression profiling and quantitative morphometric analysis. The ultrastructural lesion most strongly associated with transcriptional regulation was cortical interstitial fractional volume (VvInt), an index of tubule-interstitial damage. Transcriptional co-expression network analysis identified 1843 transcripts that correlated significantly with VvInt. These transcripts were enriched for pathways associated with mitochondrial dysfunction, inflammation, migratory mechanisms, and tubular metabolic functions. Pathway network analysis identified IL-1β as a key upstream regulator of the inflammatory response and five transcription factors cooperating with p53 to regulate metabolic functions. VvInt-associated transcripts showed significant correlation with the urine albumin to creatinine ratio and measured glomerular filtration rate 10 years after biopsy, establishing a link between the early molecular events and long-term disease progression. Thus, molecular mechanisms active early in diabetic kidney disease were revealed by correlating intrarenal transcripts with quantitative morphometry and long-term outcomes. This provides a starting point for identification of urgently needed therapeutic targets and non-invasive biomarkers of early diabetic kidney disease.
Keywords: diabetic nephropathy; longitudinal phenotype; morphogenomics; pathway networks; transcriptomic profiling.
Copyright © 2017 International Society of Nephrology. All rights reserved.
Conflict of interest statement
The remaining authors declare no competing financial interest relevant to this research article.
Figures
Comment in
-
Molecular, histological, and clinical phenotyping of diabetic nephropathy: valuable complementary information?Kidney Int. 2018 Feb;93(2):308-310. doi: 10.1016/j.kint.2017.10.026. Kidney Int. 2018. PMID: 29389397
References
-
- Collins AJ, Foley RN, Herzog C, et al. US Renal Data System 2012 Annual Data Report. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2013;61(1 Suppl 1):A7–e1. - PubMed
-
- Zhuo X, Zhang P, Barker L, et al. The lifetime cost of diabetes and its implications for diabetes prevention. Diabetes care. 2014;37(9):2557–2564. - PubMed
-
- de Boer IH, Rue TC, Cleary PA, et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Archives of internal medicine. 2011;171(5):412–420. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
